Peer Review reports
From: Active surveillance should be considered for select men with Grade Group 2 prostate cancer
| Original Submission | ||
|---|---|---|
| 14 Feb 2023 | Submitted | Original manuscript |
| 25 Feb 2023 | Reviewed | Reviewer Report - Mark S. Soloway |
| 7 Mar 2023 | Reviewed | Reviewer Report - Theodorus van der Kwast |
| 22 Mar 2023 | Reviewed | Reviewer Report |
| 12 May 2023 | Author responded | Author comments - Sigrid V. Carlsson |
| Resubmission - Version 2 | ||
| 12 May 2023 | Submitted | Manuscript version 2 |
| 24 May 2023 | Author responded | Author comments - Sigrid V. Carlsson |
| Resubmission - Version 3 | ||
| 24 May 2023 | Submitted | Manuscript version 3 |
| 25 May 2023 | Author responded | Author comments - Sigrid V. Carlsson |
| Resubmission - Version 4 | ||
| 25 May 2023 | Submitted | Manuscript version 4 |
| 26 May 2023 | Author responded | Author comments - Sigrid V. Carlsson |
| Resubmission - Version 5 | ||
| 26 May 2023 | Submitted | Manuscript version 5 |
| Publishing | ||
| 3 Sep 2023 | Editorially accepted | |
| 30 Sep 2023 | Article published | 10.1186/s12894-023-01314-6 |
You can find further information about peer review here.